SOUTHERN DERBYSHIRE Nebuliser Guidelines
|
|
- Camilla Benson
- 7 years ago
- Views:
Transcription
1 Controlled Document Ref: G053 Issue: 1 Folder Section: 15 - Respiratory Approval Date: March 2010 Review Date: March 2012 SOUTHERN DERBYSHIRE Nebuliser Guidelines For patients with chronic respiratory conditions including COPD but excluding asthma Policy Reference: G053 Version: 2 Ratified by: Patient Safety and Quality Name of Originator/Author: Vanessa Vale, Jenny Russell and Jean Sugden Name of responsible committee or Patient Safety and Quality individual: Date Issued: March 2010 Review Date: March 2011 Target Audience: AIR team, District Nurses, Palliative Care
2 CONTENTS Summary Page 2 Nebuliser Referrals Page 3 Routine referrals Page 3 Urgent referrals Page 5 Palliative care referrals Page 6 Provision of equipment for care homes Page 7 Nebuliser assessments Page 8 Nebuliser assessment process Page 9 Nebuliser Trial forms Trial A Page 10 Trial B Page 11 Referral forms South Derbyshire County and NHS Derby City Page 12 Page 1 of 12
3 1. Introduction Summary The aim of nebuliser therapy is to deliver a therapeutic dose of a desired drug as an aerosol in the form of respirable particles within a fairly short period of time, 5-10 minutes [British Thoracic Society, Nebuliser Treatment Best Practice Guideline 1997]. It is recommended that before such treatment is prescribed every patient should be assessed fully by a respiratory clinician who has had training in the supervision of nebuliser treatment. Nebulisers are useful when large doses of inhaled drugs are needed, when patients are too ill or otherwise unable to use hand held inhalers and when drugs are not available in hand held inhalers. In patients experiencing an exacerbation of COPD, if the exacerbation is relatively mild treatment with a hand held inhaler should be given using mg salbutamol. In more acute cases nebulised bronchodilators using 2.5-5mg salbutamol should be given [British Thoracic Society, Nebuliser Treatment Best Practice Guideline, 1997]. There is no significant difference in outcomes between patients treated with regular 2.5mg of salbutamol instead of 5mg [NICE COPD Guidelines 2004]. 2. Purpose The purpose of these guidelines is to provide all staff employed by NHS Derby City PCT, who administer nebulised therapy, with a framework for a standardised approach to the provision of a formal nebuliser assessment and nebulised therapy. 3. Responsibility and Accountability It is the responsibility of all Health Care Professionals who administer nebulised therapy to be aware of and adhere to the NHS Derby City PCT guidelines. 4. Patients Covered These guidelines are applicable to all patients with confirmed chronic respiratory conditions including Chronic Obstructive Pulmonary Disease, excluding asthma, who are treated as inpatients, outpatients and within their own homes. All patients with Asthma should be referred directly to secondary care and patients with palliative care needs should be referred directly to a District Nurse. Page 2 of 12
4 Nebuliser Referrals Referrals for nebuliser assessments have been separated into three categories: 1. Routine 2. Urgent 3. Palliative Care 1. ROUTINE REFERRALS All routine requests for a nebuliser assessment should be sent to the Adult Integrated Respiratory (AIR) Team [NHS Derby City]. This will ensure that all assessments for nebuliser therapy and ordering of equipment are carried out by an appropriate respiratory clinician. It is necessary for ALL referrers to identify initial indications and carry out an assessment prior to referral to ensure that it is appropriate. Routine Referral Process Identify initial indications Carry out referral assessment Complete referral form and fax it to the appropriate community respiratory team STEP ONE - Initial Indications Patients should be identified from the following indications BEFORE being referred for an assessment: 1. Experiencing persistent symptoms despite adequate bronchodilator therapy 2. Frequent exacerbations 3. Inability to use inhalers STEP TWO - Referral Assessment Carry out the following assessment BEFORE referring patients for a nebuliser assessment: 1. Confirm diagnosis - if diagnosis in doubt refer to the appropriate community respiratory team or secondary care 2. Confirm optimal therapy of bronchodilators via Metered Dose Inhaler [MDI] and spacer and check patients understand the correct use and technique 3. Carry out treatment review 4. Confirm that the patient, or carer, has a good level of understanding and dexterity required to take part in a nebuliser trial. Page 3 of 12
5 STEP THREE - Referral to AIR Team 1. Complete an AIR team referral form, including as much information as possible 2. Fax to: NHS Derby City Fax Tel: Amber Valley, Erewash, Derbyshire Dales and South Derbyshire and Derby City 3. The appropriate community respiratory team will arrange to see the patient within four weeks Referrals for nebuliser assessments are accepted from: 1. Primary Care GP s and Practice Nurses or any other appropriate Health Care Professional. 2. Secondary Care For patients within secondary care it is the responsibility of the secondary care respiratory clinician to carry out a formal assessment and issue a nebuliser accordingly. If a patient is admitted to hospital and given nebulised therapy, the treatment should be changed to a hand held inhaler and patients should be observed for hours before discharge from hospital. [British Thoracic Society, Nebuliser Treatment Best Practice Guideline, 1997]. Patients on the early discharge scheme from hospital will have their nebulisers managed by the respiratory team in the community. All COPD patients discharged with a nebuliser, should be reviewed within one month post discharge by the AIR Team. 3. Community Hospitals Patients on nebulised therapy should be weaned off nebulised therapy and onto inhaled therapy prior to discharge. If this is unsuccessful then a referral should be made to the AIR Team using the correct referral form at least two weeks prior to discharge. The patients will then be seen within four weeks of Discharge. Page 4 of 12
6 2. URGENT REFERRALS All urgent requests should be dealt with by the appropriate clinician at the time they are presented. For patients presenting with an exacerbation, it should be sufficient to increase their current reliever medication via a hand held inhaler and spacer device. If a patient is already on maximal bronchodilator therapy with stable oxygen saturation it may be appropriate to issue the patient with a nebuliser. This should then be followed up by an urgent referral to the appropriate AIR Team who will arrange to see the patient within two working days. Urgent Referrals Process Patient presents with exacerbation GP to increase current reliever medication e.g. 400mcg Salbutamol QDS, via hand held inhaler and spacer device OR If already on maximal bronchodilator therapy with stable oxygen saturation Consider hospital admission OR Send urgent referral to appropriate AIR Team Page 5 of 12
7 3. PALLIATIVE CARE REFERRALS All palliative care requests should be dealt with by the appropriate clinician as required. For patients with palliative care needs, nebulisers should be issued by the community clinician involved in the patients care. Ordering of equipment can be authorised by the nominated network leads at NHS Derby City. Prior to authorisation the following should be checked by the network lead: Does the patient have a confirmed diagnosis of COPD or asthma? What is to be administered? Who made the request for the nebuliser? After authorisation to order the equipment and the patient being issued with a nebuliser, it is the responsibility of the community clinician to provide a follow up and on-going care of patients. Palliative Care Referral Process Nebuliser required for palliative care Obtain authorisation to place order by nominated network lead Order and issue nebuliser On-going care provided by issuer of nebuliser Page 6 of 12
8 Provision of Equipment for Care Homes Provision of equipment to Care Homes should be based on an assessment of need with the assessor utilising recognised accredited tools, scales and clinical guidance / agreed local protocols [Provision of Community Equipment for Care Homes in Derbyshire and Derby City PCT Guidelines 2007]. Assessment should be undertaken by a relevant professional and all staff assessing for equipment must be competent and confident, having received appropriate training. CARE HOME REFERRALS Care homes without qualified nursing staff All patients in care [residential] homes without qualified nursing staff should be referred for a formal assessment via the Community Specialist Respiratory Team using the appropriate referral form. Once a formal assessment has been undertaken the respiratory clinician will determine the best treatment and follow up the patient within an agreed timescale. When equipment is provided to the care home and it is no longer required by the person being cared for, it is the responsibility of the care home to notify the supplier immediately so that arrangements can be made to return the equipment. Care homes with qualified nursing staff All patients who meet the referral criteria for a nebuliser should be referred for assessment to the appropriate community respiratory team. If a nebuliser is required it is the responsibility of the care home to purchase and service the equipment. Page 7 of 12
9 Nebuliser Assessments Nebuliser therapy is a specialist therapy. It is recommended that formal assessments for nebuliser therapy should be carried out for all patients. This will ensure that objective evidence is provided stating that using a nebuliser will benefit the patient along with identifying any patients that have been prescribed a nebuliser inappropriately due to the lack of a formal assessment. The NICE COPD Guidelines [2004] state that nebuliser therapy should not be prescribed or continue to be prescribed without assessing and confirming that one or more of the following occurs: - A reduction in symptoms - An increase in the ability to undertake activities of daily living and exercise capacity - An improvement in lung function It also states that if therapy is prescribed, the patient should be provided with equipment, servicing, advice and support. Page 8 of 12
10 NEBULISER ASSESSMENT PROCESS Fax referral form received Appointment made 1 st Visit Assessment Confirm diagnosis Assess exercise tolerance and breathlessness scores. Check patient compliant with treatment and has written information to support the process Increase short acting reliever treatment for 2 weeks Salbutamol 100mcg, 4 puffs, QDS via spacer 2 nd Visit End of 2 week Trial Re-assess exercise tolerance and breathlessness scores Nebuliser NOT required 1 st nebulised treatment given to patient for 2 weeks If on Tiotropium follow nebuliser trial A [page 9] if not using Tiotropium follow nebuliser trial B [page 10] 3 rd Visit End of 2 week Trial Re-assess exercise tolerance and breathlessness scores Agree on method of most effective treatment with patient Continue nebulised therapy Stop nebulised therapy Give patient management plan, advice and nurse contact details Give patient management plan, advice and nurse contact details Refer back to GP and discharge episode of care Refer back to GP and discharge episode of care Page 9 of 12
11 Nebuliser Trial A Tiotropium Prescribed Patient Name: Date of Birth: / / NHS No: Date: YOUR TRIAL WILL LAST FOUR WEEKS STEP ONE week 1 and 2 Medicine Dose Salbutamol 100mcg INHALER 4 PUFFS 4 times a day with SPACER DEVICE ANSWER THE FOLLOWING QUESTIONS AT THE END OF WEEK 2 QUESTION Y or N COMMENTS Has the treatment made a difference? Is your breathing easier in any way? Can you do some things that you couldn t do before? Can you do the same things but faster? Are you less breathless when you do things that you did before? Has your sleep improved? [Fill in MRC and Oxygen Cost Diagram] STEP TWO week 2 and 3 Medicine Dose Salbutamol 2.5mg NEBULISER SOLUTION 1 Nebule 4 times a day in NEBULISER ANSWER THE FOLLOWING QUESTIONS AT THE END OF WEEK 4 QUESTION Y or N COMMENTS Has the treatment made a difference? Is your breathing easier in any way? Can you do some things that you couldn t do before? Can you do the same things but faster? Are you less breathless when you do things that you did before? Has your sleep improved? [Fill in MRC and Oxygen Cost Diagram] Page 10 of 12
12 Nebuliser Trial B Tiotropium Not Prescribed Patient Name: Date of Birth: / / NHS No: Date: YOUR TRIAL WILL LAST FOUR WEEKS Medicine Salbutamol 100mcg INHALER Ipratropium 20mcg STEP ONE week 1 and 2 Dose 4 PUFFS 4 times a day with SPACER DEVICE 4 PUFFS 4 times a day with Spacer Device ANSWER THE FOLLOWING QUESTIONS AT THE END OF WEEK 2 QUESTION Y / N COMMENTS Has the treatment made a difference? Is your breathing easier in any way? Can you do some things that you couldn t do before? Can you do the same things but faster? Are you less breathless when you do things that you did before? Has your sleep improved? [Fill in MRC and Oxygen Cost Diagram] STEP TWO week 2 and 3 Medicine Dose Salbutamol 2.5mg [Nebuliser Solution] 1 NEBULE 4 times a day in NEBULISER Ipratropium 500mg [Nebuliser Solution] 1 NEBULE 4 times a day in NEBULISER FILL THE FOLLOWING QUESTIONS AT THE END OF WEEK 4 QUESTION Y / N COMMENTS Has the treatment made a difference? Is your breathing easier in any way? Can you do some things that you couldn t do before? Can you do the same things but faster? Are you less breathless when you do things that you did before? Has your sleep improved? [Fill in MRC and Oxygen Cost Diagram] Page 11 of 12
13 Name: Address: DOB: Tel: NHS No: GP: Practice: Postcode: Alternative Contact: Name: Relationship: Tel: Mobile: GP tel no: Does patient require a home visit? Y / N Does the patient need an interpreter? Y / N Any known risks for staff visiting alone? Y / N If Yes, please state language: Does the patient live alone? Y / N Diagnosis and date of onset (include any relevant medical history and a current medication list) Is the patient aware of their diagnosis? Y / N Spirometry Date performed: FEV 1: %predicted: FVC: FEV 1/FVC: Reason for referral: Active follow-up of patients recently discharged from hospital Date of discharge: Management of respiratory condition Nebuliser assessment / follow-up Unconfirmed diagnosis of COPD for spirometry Inspire COPD education group Priority: Urgent Priority 1 patient contacted within 2 working days Priority 3 within 2 weeks Priority 2 patient contacted within 5 working days Routine usually within 4 weeks Problems identified: Recurrent infection / exacerbations Repeated hospital admissions for chest Sputum clearance problems Disordered breathing pattern Increased breathlessness Panic / anxiety Decreased exercise tolerance Limited knowledge of condition Other services involved: Referred by: Designation: Contact address: Contact number: Date of referral: Please return to: AIR Team Coleman Health Centre Coleman Street Alvaston Derby DE24 8NH Tel: Fax: Page 12 of 12
Please see the NHS Surrey Nebulised Treatment Pathway attached below.
Surrey Primary Care Trust Cedar Court Guildford Road Leatherhead KT22 9AE Tel: 01372 201700 Fax: 01372 201706 www.surreyhealth.nhs.uk November 11 th 2010 To: NHS Surrey GP s and Walk in Centre staff Re:
More informationPathway for Diagnosing COPD
Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational
More informationCOPD - Education for Patients and Carers Integrated Care Pathway
Patient NHS COPD - Education for Patients and Carers Integrated Care Pathway Date ICP completed:. Is the patient following another Integrated Care Pathway[s].. / If yes, record which other Integrated Care
More informationCOPD PROTOCOL CELLO. Leiden
COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on
More informationLothian Guideline for Domiciliary Oxygen Therapy Service for COPD
Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD This document describes the standard for clinical assessment, prescription, optimal management and follow-up of patients receiving domiciliary
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
More informationManagement of exacerbations in chronic obstructive pulmonary disease in Primary Care
Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant morbidity and mortality.
More informationPulmonary Rehabilitation in Newark and Sherwood
Pulmonary Rehabilitation in Newark and Sherwood With exception of smoking cessation pulmonary rehabilitation is the single most effective intervention for any patient with COPD. A Cochrane review published
More informationMedication and Devices for Chronic Obstructive Pulmonary Disease (COPD)
Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD) Patients with COPD take a wide variety of medicines to manage their symptoms these include: Inhaled Short Acting Bronchodilators
More informationCOPD RESOURCE PACK SECTION 11. Fife Integrated COPD Care Pathways
COPD RESOURCE PCK SECTION 11 Fife Integrated COPD Care Pathways In this section: 1. COPD Guidance treatment at each stage of the disease 2. Overview of Respiratory (COPD) Integrated Pathway 3. Chronic
More informationBefore prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines.
Formulary Guidance for Management of COPD patients Before prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines. For inhaler
More informationGuidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma Important Complete asthma control needs to be achieved for at least 12 weeks before attempting
More informationThe patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
More informationPLAN OF ACTION FOR. Physician Name Signature License Date
PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes
More informationDrug therapy SHORT-ACTING BETA AGONISTS SHORT-ACTING ANTICHOLINERGICS LONG-ACTING BETA AGONISTS LONG-ACTING ANTICHOLINERGICS
Drug therapy 6 6.1 What is the role of bronchodilators in COPD? 52 SHORT-ACTING BETA AGONISTS 6.2 How do short-acting beta agonists work? 52 6.3 What are the indications for their use? 52 6.4 What is the
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationSandwell Community Respiratory Service
Contents Page Community Respiratory Service 2 Service times and locations 3 Oxygen Service 4 Pulmonary Rehabilitation 5 Maintenance Programme 6 Occupational Therapy 7 Dietary support and advice 7 Weatherwise
More informationPulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Development of disability in COPD The decline in airway function may initially go unnoticed as people adapt their lives to avoid
More informationChronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways
More informationWandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15
Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15 April 2015 Dr Kieron Earney & Kate Symons Acknowledgements Dr Sarah Deedat Public Health Lead for Long Term Conditions 1 1.
More informationSkill Levels for Delivering High Quality Asthma and COPD Respiratory Care by Nurses in Primary Care
Skill Levels for Delivering High Quality Asthma and COPD Respiratory Care by Nurses in Primary Care September 2007 Revised December 2009, April 2014 Author: Ruth McArthur In conjunction with the PCRS-UK
More informationShared Care Guideline-Use of Donepezil, Galantamine, Rivastigmine and Memantine in Dementia
Shared Care Guideline-Use of Donepezil, Galantamine, Rivastigmine and Memantine in Dementia Version: 3.0 Ratified by: Medicines Committee Date ratified: 16 th November 2011 Name of originator/author: James
More informationCommunity health care services Alternatives to acute admission & Facilitated discharge options. Directory
Community health care services Alternatives to acute admission & Facilitated discharge options Directory Introduction The purpose of this directory is to provide primary and secondary health and social
More informationAdult Home Oxygen Therapy. Purpose To provide guidance on the requirements for and procedures relating to domiciliary oxygen therapy.
Contents Purpose... 1 Scope/Audience... 1 Categories for Home Oxygen Therapy... 2 Assessment for Home Oxygen Therapy... 3 Investigations... 3 Requests for home oxygen... 3 Provision of Home Oxygen... 4
More informationWAY OF WORKING LUNG PATIENTS
WAY OF WORKING LUNG PATIENTS CELLO Leiden May 2011 Introduction CELLO, the cooperation of primary health care practitioners in Leiden and surroundings, is an organisation of independently working general
More informationSponsor Novartis Pharmaceuticals
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study
More informationBronchodilators in COPD
TSANZSRS Gold Coast 2015 Can average outcomes in COPD clinical trials guide treatment strategies? Long live the FEV1? Christine McDonald Dept of Respiratory and Sleep Medicine Austin Health Institute for
More informationIrish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy
31 st Irish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy 1 Introduction Chronic obstructive pulmonary disease (COPD) is an important disease for patients, the health
More informationCOPD Prescribing Guidelines
South Staffordshire Area Prescribing Group COPD Prescribing Guidelines Inhaler choices in this guideline are different from previous versions produced by the APG. It is not expected patients controlled
More informationService delivery interventions
Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P
More informationCoding Guidelines for Certain Respiratory Care Services July 2014
Coding Guidelines for Certain Respiratory Care Services Overview From time to time the AARC receives inquiries about respiratory-related coding and coverage issues through its Help Line or Coding Listserv.
More informationExploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway. Health Quality Ontario s integrated episode of care for COPD
Exploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway Health Quality Ontario s integrated episode of care for COPD Dr. Charlie Chan Health Quality Ontario Expert Panel Co-Chair May/June
More informationConsultation: Two proposals for registered nurse prescribing
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
More informationBreathe With Ease. Asthma Disease Management Program
Breathe With Ease Asthma Disease Management Program MOLINA Breathe With Ease Pediatric and Adult Asthma Disease Management Program Background According to the National Asthma Education and Prevention Program
More informationJames F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
More informationApplicant Information Sheet for MASS 45 Adult Oxygen: Initial Application and 4 Month Review
, Queensland Health Applicant Information Sheet for Applicants should retain this section for their records Eligibility Administrative eligibility is dependent upon the applicant being a permanent Queensland
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
More informationSTATE OF NEBRASKA STATUTES RELATING TO RESPIRATORY CARE PRACTICE ACT
2012 STATE OF NEBRASKA STATUTES RELATING TO RESPIRATORY CARE PRACTICE ACT Department of Health and Human Services Division of Public Health Licensure Unit 301 Centennial Mall South, Third Floor PO Box
More informationBest Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) DuPage Medical Group Case Study Organization Profile Established in 1999, DuPage Medical Group (DMG) is a multispecialty
More informationService Specification Template Department of Health, updated June 2015
Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st
More informationHospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care
Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care Charley P. Starnes, RRT, RCP Clinical Respiratory Specialist- COPD Education Important Milestones July 2011-
More informationNational Institute for Health and Care Excellence. NICE Quality Standards Consultation Idiopathic Pulmonary Fibrosis
National Institute for Health and Care Excellence NICE Quality Standards Consultation Idiopathic Pulmonary Fibrosis Closing date: 5pm Tuesday 23 September 2014 Organisation Title Name Job title or role
More informationunderstanding the professional guidelines
SEVERE ASTHMA understanding the professional guidelines This guide includes information on what the European Respiratory Society (ERS) and the American Thoracic Society (ATS) have said about severe asthma.
More informationRES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP
RES/006/APR16/AR Speaker : Dr. Pither Sandy Tulak SpP Definition of Asthma (GINA 2015) Asthma is a common and potentially serious chronic disease that imposes a substantial burden on patients, their families
More informationSouthwark Clinical Commissioning Group Lambeth Clinical Commissioning Group
Getting the Vision Right: A multi-disciplinary approach to providing integrated care for respiratory patients Dr Noel Baxter, GP NHS Southwark CCG Dr Irem Patel, Integrated Consultant Respiratory Physician
More informationCosting statement: Depression: the treatment and management of depression in adults. (update) and
Costing statement: Depression: the treatment and management of depression in adults (update) and Depression in adults with a chronic physical health problem: treatment and management Summary It has not
More information3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients
Faculty Disclosures COPD Disease Management Tackling the Transition Dr. Cappelluti has no actual or potential conflicts of interest associated with this presentation. Jane Reardon has no actual or potential
More informationSevere asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital
Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,
More informationThe Annual Direct Care of Asthma
The Annual Direct Care of Asthma The annual direct health care cost of asthma in the United States is approximately $11.5 billion; indirect costs (e.g. lost productivity) add another $4.6 billion for a
More informationTHE MANAGEMENT OF ASTHMA IN SCHOOL
THE MANAGEMENT OF ASTHMA IN SCHOOL 1 BACKGROUND 1.1 This school recognises that asthma is an important condition affecting many school children and positively welcomes all pupils with asthma. It recognises
More informationYour Go-to COPD Guide
Your Go-to COPD Guide Learning how to live with chronic obstructive pulmonary disease (COPD) Inside, you ll learn: COPD facts COPD symptoms and triggers How to talk with your doctor Different treatment
More informationCOPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
More informationPSYCHOLOGICAL SERVICES TO RESPIRATORY MEDICINE 2011 ANNUAL REPORT EXECUTIVE SUMMARY
Whittington Health PSYCHOLOGICAL SERVICES TO RESPIRATORY MEDICINE 2011 ANNUAL REPORT WHITTINGTON HEALTH INTEGRATED CARE ORGANIZATION EXECUTIVE SUMMARY This report describes the service initiatives, clinical
More informationMedicines Use Review Supporting Information for Asthma Patients
Medicines Use Review Supporting Information for Asthma Patients What is asthma? Asthma is a chronic inflammatory disorder of the airways. The inflammation causes an associated increase in airway hyper-responsiveness,
More informationDisease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification
Disease Management UnitedHealthcare Disease Management (DM) programs are part of our innovative Care Management Program. Our Disease Management (DM) program is guided by the principles of the UnitedHealthcare
More informationCompare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma
Chapter 31 Drugs Used to Treat Lower Respiratory Disease Learning Objectives Describe the physiology of respirations Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis,
More informationJOB DESCRIPTION. ellenor. Head of Adult Community Services Director of Patient Care
JOB DESCRIPTION ellenor Clinical Nurse Specialist Responsible to: Accountable to: Head of Adult Community Services Director of Patient Care General ellenor is a specialist palliative care provider for
More informationAsthma, anxiety & depression
Anxiety and are common in people with asthma. The good news is that there are effective treatments both for asthma and for anxiety and. With careful management, the symptoms of anxiety and can be treated
More informationKey Performance Indicator (KPI) Matrix for Performance Measurement Framework Integrated TB Services (ITBS)
Group Color Legend: ITBS Contact ITBS Disease ITBS Identification ITBS LTBI Pillars of Excellence (What we are measuring) Customer Satisfaction Quality and Delivery and Utilization Resource Management
More informationBetter Breathing with COPD
Better Breathing with COPD People with Chronic Obstructive Pulmonary Disease (COPD) often benefit from learning different breathing techniques. Pursed Lip Breathing Pursed Lip Breathing (PLB) can be very
More informationNational Learning Objectives for COPD Educators
National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the
More informationRespiratory Care. A Life and Breath Career for You!
Respiratory Care A Life and Breath Career for You! Respiratory Care Makes a Difference At 9:32 am, Lori Moreno brought a newborn baby struggling to breathe back to life What have you accomplished today?
More informationShared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
More informationCLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease
CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts
More informationMedicines reconciliation on admission and discharge from hospital policy April 2013. WHSCT medicines reconciliation policy 1
Medicines reconciliation on admission and discharge from hospital policy April 2013 WHSCT medicines reconciliation policy 1 Policy Title Policy Reference Number Medicines reconciliation on admission and
More informationCOPD. Information brochure for chronic obstructive pulmonary disease.
COPD Information brochure for chronic obstructive pulmonary disease. CONTENTS What does COPD mean?...04 What are the symptoms of COPD?...06 What causes COPD?...09 Treating COPD...10 Valve therapy in COPD...12
More informationGUIDELINES FOR THE MANAGEMENT OF OXYGEN THERAPY
SOUTH DURHAM HEALTH CARE NHS TRUST GUIDELINES FOR THE MANAGEMENT OF OXYGEN THERAPY AIM To supplement oxygen intake using the appropriate equipment in order to correct hypoxia and relieve breathlessness.
More informationConsultation: Two proposals for registered nurse prescribing
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
More informationStrategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology
Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education Chris Orelup, MS3 Max Project 3/1/01 Pediatric Asthma The leading cause of illness in childhood 10, 000, 000 school absences
More information5. Treatment of Asthma in Children
Treatment of sthma in hildren 5. Treatment of sthma in hildren 5.1 Maintenance Treatment 5.1.1 rugs Inhaled Glucocorticoids. Persistent wheezing in children under the age of three can be controlled with
More informationSunderland Psychological Wellbeing Service
Sunderland Psychological Wellbeing Service Information for Referrers Offering a range of psychological therapies across Sunderland. To make a referral call 0191 566 5454 A partnership between Northumberland,
More informationAppendix 3 INDIVIDUAL PATIENT DRUG TREATMENT. POLICY AND PROCESS FOR DECISION MAKING September 2007
Appendix 3 INDIVIDUAL PATIENT DRUG TREATMENT POLICY AND PROCESS FOR DECISION MAKING September 2007 Approved by Board: 6 th September 2007 Date Implemented: 1 st October 2007 Review Date: September 2008
More informationConsultation: Two proposals for registered nurse prescribing
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Drugs for the treatment of Remit / Appraisal objective: Final scope To appraise the clinical and cost effectiveness of
More informationIdiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis What is Idiopathic Pulmonary Fibrosis? Idiopathic pulmonary fibrosis (IPF) is a condition that causes persistent and progressive scarring of the tiny air sacs (alveoli) in
More informationBritish Thoracic Society. Quality Standards for Pulmonary Rehabilitation in Adults MAY 2014 ISSN 2040-2023
British Thoracic Society Quality Standards for Pulmonary Rehabilitation in Adults MAY 2014 ISSN 2040-2023 BRITISH THORACIC SOCIETY REPORTS VOL. 6 NO. 2 2014 British Thoracic Society Quality Standards for
More informationPATIENT ACCESS POLICY
. PATIENT ACCESS POLICY TITLE Patient Access Policy APPLICABLE TO All administrative / clerical / managerial staff involved in the administration of patient pathway. All medical and clinic staff seeing
More informationAnnounced Follow-Up Inspection Dignity and Essential Care
Announced Follow-Up Inspection Dignity and Essential Care Cardiff and Vale University Health Board University Hospital of Wales Ward B7 Date of 29 th April 2014 1 HIW Follow-Up Inspection: Ward B7, University
More informationVersion 2 This guideline describes how to manage patients who are showing signs and symptoms of alcohol withdrawal and Wernicke s Encephalopathy.
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality A Guideline for the Management of Acute Alcohol Withdrawal
More informationProving Respiratory Therapy value in the Affordable Care Pay Structure
Proving Respiratory Therapy value in the Affordable Care Pay Structure The Curve 2 2 No Margin No Mission (FFS) Outcomes 3 * 2001 study in five states found that medical debt contributed to 46.2% of all
More informationConsultation: Two proposals for registered nurse prescribing
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
More informationConsultation: Two proposals for registered nurse prescribing
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
More informationKey Performance Indicator (KPI) Matrix for Performance Measurement Framework
Color Legend: TB Contact and Investigation and Identification LTBI WRHA Program: Tuberculosis Pillars of Excellence (What we are measuring) Customer Satisfaction Quality and Outcomes Delivery and Utilization
More informationRivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)
Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE) Amber Drug Level 2 Leeds We have started your patient on rivaroxaban for the treatment of provoked VTE (deep
More informationAsthma Management Policy
Asthma Management Policy Policy Number 003 Version Number 1.01 Drafted by Executive Officer Approved Date: Review Date: Responsibility Relevant Policies Relevant Standards and Regulations Bubup Womindjeka
More informationCommissioning Policy. Defining the boundaries between NHS and Private Healthcare
Commissioning Policy Defining the boundaries between NHS and Private Healthcare Reference No: Version: 1 Ratified by: PH007 East Midlands Specialised Commissioning Group Board (EMSCG) June 2009 Date ratified:
More informationAsthma Guidance for Birmingham Schools.
Asthma Guidance for Birmingham Schools. May 2004 RECOMMENDED ASTHMA GUIDANCE FOR SCHOOL STAFF* This guidance is intended to complement the local Birmingham Administration and Management of Prescribed Medicines
More informationUnderstanding COPD Questionnaire
Further information about the UCOPD questionnaire is available from http://www.science.ulster.ac.uk/ucopd/ or by contacting Dr Brenda O Neill (b.oneill@ulster.ac.uk) Understanding COPD Questionnaire Patient
More informationBreakfast symposium: From hospital to home - the focus on the patient
Breakfast symposium: From hospital to home - the focus on the patient Nadya Hamedi DARZI Fellow UCLPartners and Barts Health NHS Trust in collaboration with North Central London Local Pharmaceutical Committee
More informationConsultation: Two proposals for registered nurse prescribing
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
More informationTable 1 Performance Measures. Quality Monitoring P4P Yr1 Yr2 Yr3. Specification Source. # Category Performance Measure
Table 1 Performance Measures # Category Performance Measure 1 Behavioral Health Risk Assessment and Follow-up 1) Behavioral Screening/ Assessment within 60 days of enrollment New Enrollees who completed
More informationINDIGENOUS CHRONIC DISEASE PACKAGE CARE COORDINATION AND SUPPLEMENTARY SERVICES PROGRAM GUIDELINES
CLOSING THE GAP tackling disease INDIGENOUS CHRONIC DISEASE PACKAGE CARE COORDINATION AND SUPPLEMENTARY SERVICES PROGRAM GUIDELINES November 2012 CONTENTS 1. Introduction... 3 Program Context... 3 Service
More informationMedication Policy and Procedures
Medication Policy and Procedures Policy Number: 2009/10 Approved by: Heritage Management Committee 10 November 2009 Last reviewed: October 2009 Next review due: November 2011 Policy Statement Studies of
More informationPatient Electronic Alert to Key-worker System (PEAKS) Guidelines
Patient Electronic Alert to Key-worker System (PEAKS) Guidelines This procedural document supersedes: PAT/EC 4 v.1 Guidelines for Patient Electronic Alert to Key-worker systems (PEAKS). Did you print this
More informationKENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
More informationQUALITY ACCOUNT 2015-16
QUALITY ACCOUNT 2015-16 CONTENTS Part 1 Chief Executive s statement on quality... 3 Vision, purpose, values and strategic aims... 4 Part 2 Priorities for improvement and statement of assurance... 5 2.1
More informationContact: Jessica Lorenzo, M.P.H., Senior Project Manager. E-mail: Jessica.Lorenzo@mountsinai.org
Mount Sinai School of Medicine: Improving Access to High Quality Asthma Care in East Harlem Grant Results Report October 2008 BACKGROUND INFORMATION Mount Sinai School of Medicine Division of General Internal
More informationKIH Cardiac Rehabilitation Program
KIH Cardiac Rehabilitation Program For any further information Contact: +92-51-2870361-3, 2271154 Feedback@kih.com.pk What is Cardiac Rehabilitation Cardiac rehabilitation describes all measures used to
More informationElectronic patient diaries in clinical research
Topics Electronic diaries in Clinical Trials Electronic diaries versus Paper Electronic patient diaries in clinical research Case Study: Novel detection of exacerbations of COPD with patient reported outcome
More informationFerry Beach Ecology School Medical Management Plan -- Student with Chronic Illness or Severe Allergy
Medical Management Plan -- Student with Chronic Illness or Severe Allergy Students at Ferry Beach Ecology School (FBES) have full access to health services by a school nurse. The FBES nurse will identify
More information